BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31494943)

  • 1. Impact of left ventricular assist device therapy on the cardiac proteome and metabolome composition in ischemic cardiomyopathy.
    Shahinian JH; Rog-Zielinska EA; Schlimpert M; Mayer B; Tholen S; Kammerer B; Biniossek ML; Beyersdorf F; Schilling O; Siepe M
    Artif Organs; 2020 Mar; 44(3):257-267. PubMed ID: 31494943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomics highlights decrease of matricellular proteins in left ventricular assist device therapy†.
    Shahinian JH; Mayer B; Tholen S; Brehm K; Biniossek ML; Füllgraf H; Kiefer S; Heizmann U; Heilmann C; Rüter F; Grapow M; Reuthebuch OT; Eckstein F; Beyersdorf F; Schilling O; Siepe M
    Eur J Cardiothorac Surg; 2017 Jun; 51(6):1063-1071. PubMed ID: 28329269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic profiling of the human failing heart after left ventricular assist device support.
    de Weger RA; Schipper ME; Siera-de Koning E; van der Weide P; van Oosterhout MF; Quadir R; Steenbergen-Nakken H; Lahpor JR; de Jonge N; Bovenschen N
    J Heart Lung Transplant; 2011 May; 30(5):497-506. PubMed ID: 21211997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac unloading by LVAD support differentially influences components of the cGMP-PKG signaling pathway in ischemic and dilated cardiomyopathy.
    Persoon S; Paulus M; Hirt S; Jungbauer C; Dietl A; Luchner A; Schmid C; Maier LS; Birner C
    Heart Vessels; 2018 Aug; 33(8):948-957. PubMed ID: 29546540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Core functional nodes and sex-specific pathways in human ischaemic and dilated cardiomyopathy.
    Li M; Parker BL; Pearson E; Hunter B; Cao J; Koay YC; Guneratne O; James DE; Yang J; Lal S; O'Sullivan JF
    Nat Commun; 2020 Jun; 11(1):2843. PubMed ID: 32487995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescence imaging microscopy of cellular markers in ischemic vs non-ischemic cardiomyopathy after left ventricular unloading.
    Bick RJ; Bagwell SH; Jones CE; Poindexter BJ; Buja LM; Youker KA; Grigore A; Clubb F; Radovancevic B; Frazier OH
    J Heart Lung Transplant; 2005 Apr; 24(4):454-61. PubMed ID: 15797748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease-specific remodeling of cardiac mitochondria after a left ventricular assist device.
    Heerdt PM; Schlame M; Jehle R; Barbone A; Burkhoff D; Blanck TJ
    Ann Thorac Surg; 2002 Apr; 73(4):1216-21. PubMed ID: 11996266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and functional cardiac profile after prolonged duration of mechanical unloading: potential implications for myocardial recovery.
    Castillero E; Ali ZA; Akashi H; Giangreco N; Wang C; Stöhr EJ; Ji R; Zhang X; Kheysin N; Park JS; Hegde S; Patel S; Stein S; Cuenca C; Leung D; Homma S; Tatonetti NP; Topkara VK; Takeda K; Colombo PC; Naka Y; Sweeney HL; Schulze PC; George I
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1463-H1476. PubMed ID: 30141986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Nonglycolytic Glucose Metabolism in Myocardial Recovery Upon Mechanical Unloading and Circulatory Support in Chronic Heart Failure.
    Badolia R; Ramadurai DKA; Abel ED; Ferrin P; Taleb I; Shankar TS; Krokidi AT; Navankasattusas S; McKellar SH; Yin M; Kfoury AG; Wever-Pinzon O; Fang JC; Selzman CH; Chaudhuri D; Rutter J; Drakos SG
    Circulation; 2020 Jul; 142(3):259-274. PubMed ID: 32351122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Ischemic Heart Failure Etiology on Cardiac Recovery During Mechanical Unloading.
    Wever-Pinzon J; Selzman CH; Stoddard G; Wever-Pinzon O; Catino A; Kfoury AG; Diakos NA; Reid BB; McKellar S; Bonios M; Koliopoulou A; Budge D; Kelkhoff A; Stehlik J; Fang JC; Drakos SG
    J Am Coll Cardiol; 2016 Oct; 68(16):1741-1752. PubMed ID: 27737740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional mapping of myocardial hibernation phenotype in idiopathic end-stage dilated cardiomyopathy.
    Lionetti V; Matteucci M; Ribezzo M; Di Silvestre D; Brambilla F; Agostini S; Mauri P; Padeletti L; Pingitore A; Delsedime L; Rinaldi M; Recchia FA; Pucci A
    J Cell Mol Med; 2014 Mar; 18(3):396-414. PubMed ID: 24444256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible activation of nuclear factor-kappaB in human end-stage heart failure after left ventricular mechanical support.
    Grabellus F; Levkau B; Sokoll A; Welp H; Schmid C; Deng MC; Takeda A; Breithardt G; Baba HA
    Cardiovasc Res; 2002 Jan; 53(1):124-30. PubMed ID: 11744020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional heterogeneity of decreased myocardial norepinephrine and increased lipid peroxidation levels in patients with end-stage failing heart secondary to dilated or ischemic cardiomyopathy.
    Rochette L; Tatou E; Vergely C; Maupoil V; Bouchot O; Mossiat C; Jazayeri S; Benkhadra S; Brenot R; Girard C; David M
    J Heart Lung Transplant; 2008 Jul; 27(7):767-74. PubMed ID: 18582807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological findings in cardiac apex removed during implantation of left ventricular assist devices (LVAD) are non-specific: 13-year-experience at a German Heart Center.
    Strecker T; Rösch J; Weyand M; Agaimy A
    Int J Clin Exp Pathol; 2014; 7(9):5549-56. PubMed ID: 25337196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness.
    Klotz S; Foronjy RF; Dickstein ML; Gu A; Garrelds IM; Danser AH; Oz MC; D'Armiento J; Burkhoff D
    Circulation; 2005 Jul; 112(3):364-74. PubMed ID: 15998679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma neurohormone levels correlate with left ventricular functional and morphological improvement in LVAD patients.
    Thompson LO; Skrabal CA; Loebe M; Lafuente JA; Roberts RR; Akgul A; Jones V; Bruckner BA; Thohan V; Noon GP; Youker KA
    J Surg Res; 2005 Jan; 123(1):25-32. PubMed ID: 15652947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating growth differentiation factor-15 correlates with myocardial fibrosis in patients with non-ischaemic dilated cardiomyopathy and decreases rapidly after left ventricular assist device support.
    Lok SI; Winkens B; Goldschmeding R; van Geffen AJ; Nous FM; van Kuik J; van der Weide P; Klöpping C; Kirkels JH; Lahpor JR; Doevendans PA; de Jonge N; de Weger RA
    Eur J Heart Fail; 2012 Nov; 14(11):1249-56. PubMed ID: 22843564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial histological changes in dilated cardiomyopathy during a long-term left ventricular assist device support.
    Taketani S; Sawa Y; Fukushima N; Masai T; Kawaguchi N; Onishi S; Matsuda H
    Heart Vessels; 1997; 12(2):98-100. PubMed ID: 9403314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiomyopathic etiology and SERCA2a reverse remodeling during mechanical support of the failing human heart.
    Heerdt PM; Klotz S; Burkhoff D
    Anesth Analg; 2006 Jan; 102(1):32-7. PubMed ID: 16368801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional networks of nucleocytoplasmic transport-related genes differentiate ischemic and dilated cardiomyopathies. A new therapeutic opportunity.
    Molina-Navarro MM; Triviño JC; Martínez-Dolz L; Lago F; González-Juanatey JR; Portolés M; Rivera M
    PLoS One; 2014; 9(8):e104709. PubMed ID: 25137373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.